These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle.
    Author: Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, Pfitzer G.
    Journal: Biochem Biophys Res Commun; 1993 Feb 15; 190(3):968-74. PubMed ID: 8439345.
    Abstract:
    Because tyrosine kinases participate in diverse signalling pathways, we suspected that these enzymes might also participate in regulation of signal transduction in smooth muscle. Therefore, we studied the effects of geldanomycin, tyrphostin, and genistein, three structurally unrelated tyrosine kinase inhibitors, on receptor-mediated and depolarization-mediated contraction in three different types of smooth muscle. Contraction elicited by stimulation of muscarinic receptors with carbachol, or by stimulation of alpha-adrenergic receptors with norepinephrine or phenylephrine were markedly (> 80%) and reversibly inhibited by tyrosine-kinase inhibitors. In contrast, only slight inhibition (20%) occurred in contractions elicited by K(+)-induced depolorization. Moreover, tyrphostin did not inhibit direct Ca(2+)-mediated activation of the contractile apparatus in preparations permeabilized with beta-escin. These results suggest the novel hypothesis that tyrosine kinases participate in regulation of signal transduction that is associated with receptor-mediated contraction of smooth muscle.
    [Abstract] [Full Text] [Related] [New Search]